Latigo Biotherapeutics Inc. (LTGO)
NASDAQ: LTGOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
LTGO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.03B
- EPS (TTM)
- -$2.52
- Dividend yield
- None
- 52-week range
- 15.27 – 25.93
- Day range
- 15.27 – 16.35
- Volume / Avg
- 241.51K / 397.83K
- Beta
- —
- Shares outstanding
- 66.30M
- Next earnings
- Nov 12, 2026
52-week range
LTGO stock today
On Oct 7, LTGO ended the session at $15.52, shedding $0.74 (4.55%), versus the S&P 500's 0.22% decline. At this level, LTGO sits near the bottom of its 52-week range of $15.27 to $25.93: 40.1% below the high, set on Aug 27, 2026 and 1.6% above the low. Latigo Biotherapeutics has posted a net loss over the last twelve months (EPS of -$2.52), so its P/E ratio is not meaningful.
Latigo Biotherapeutics's next earnings report is expected on Nov 12, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Latigo Biotherapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2026
Earnings
Earnings history- Next report
- Nov 12, 2026
Latigo Biotherapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| OPKOPKO Health Inc. | 1.39 | -4.79% | $1.04B | vs LTGO |
| PCRXPacira BioSciences Inc. | 25.20 | +1.78% | $1.00B | vs LTGO |
| SVRASavara Inc. | 4.88 | +4.95% | $1.00B | vs LTGO |
| AKTSAktis Oncology Inc. | 18.00 | +0.78% | $1.00B | vs LTGO |
| AMPHAmphastar Pharmaceuticals Inc. | 25.54 | -1.43% | $1.09B | vs LTGO |
| BCAXBicara Therapeutics Inc. | 16.42 | -0.85% | $1.09B | vs LTGO |
| TRAXFirst Tracks Biotherapeutics Inc. | 30.59 | -2.55% | $1.09B | vs LTGO |
| JANXJanux Therapeutics Inc. | 17.92 | +6.73% | $1.10B | vs LTGO |
Indexes, lists and sector
Latigo Biotherapeutics stock FAQ
What is Latigo Biotherapeutics's stock price today?
LTGO last traded at $15.52 as of Oct 7, 4:00 PM EDT, down 4.55% on the day. Prices are delayed at least 15 minutes.
When is Latigo Biotherapeutics's next earnings date?
Latigo Biotherapeutics is expected to report earnings on Thursday, November 12, 2026.
What is the LTGO 52-week high?
The 52-week high for LTGO is $25.93 and the 52-week low is $15.27. The stock is currently 40.1% below its high.